Stocks and InvestingStocks and Investing
Mon, July 12, 2021
Sat, July 10, 2021
Fri, July 9, 2021
Thu, July 8, 2021
Wed, July 7, 2021
Tue, July 6, 2021
Mon, July 5, 2021
Fri, July 2, 2021
Thu, July 1, 2021

Zhiqiang Shu Downgraded (SNSE) to Hold and Held Target at $12 on, Jul 1st, 2021


Published on 2024-10-27 17:06:18 - WOPRAI, Zhiqiang Shu
  Print publication without navigation


Zhiqiang Shu of Berenberg, Downgraded "Sensei Biotherapeutics, Inc." (SNSE) to Hold and Held Target at $12 on, Jul 1st, 2021.

Zhiqiang has made no other calls on SNSE in the last 4 months.



There are 2 other peers that have a rating on SNSE. Out of the 2 peers that are also analyzing SNSE, 1 agrees with Zhiqiang's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kevin DeGeeter of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, June 29th, 2021


This is the rating of the analyst that currently disagrees with Zhiqiang


  • Joseph Catanzaro of "Piper Sandler" Initiated at Buy and Held Target at $25 on, Monday, March 1st, 2021